Clinical trials recruiting for Unresectable Colorectal Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BET Bromodomain Inhibitor ZEN-3694 | 1 |
| Bevacizumab | 1 |
| Capecitabine | 1 |
| Cetuximab | 1 |
| Floxuridine | 1 |
| Fluorouracil | 1 |
| Irinotecan | 1 |
| Leucovorin | 1 |
| Oxaliplatin | 1 |
| Panitumumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Illinois | 3 |
| Missouri | 3 |
| New York | 3 |
| Ohio | 3 |
| Pennsylvania | 3 |
| California | 2 |
| Colorado | 2 |
| Florida | 2 |
| Georgia | 2 |
| Indiana | 2 |
| Michigan | 2 |
| Minnesota | 2 |
Top cities
Self-screener
Recruiting trials
- LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Related conditions
Trials recruiting for Unresectable Colorectal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Unresectable Colorectal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.